Latest Posts › Prescription Drugs

Share:

Inflation Reduction Act Expected to Become Law

Key Takeaways: ..The Senate voted 51-50 on August 7 to pass the Inflation Reduction Act. ..The legislation is expected to pass the House this week without changes and to be signed by President Biden. ..The...more

Capitol Hill Healthcare Update - March 2020 #2

CORONAVIRUS WORRIES CONTINUE AFTER EMERGENCY FUNDING BILL - Congressional approval last week of emergency spending to address the coronavirus hasn’t allayed Capitol Hill’s concerns about preparedness and response as the...more

Capitol Hill Healthcare Update - March 2020 #1

CONGRESS SPEEDS TOWARD EMERGENCY CORONAVIRUS FUNDING PACKAGE - As novel coronavirus continues to sweep the globe, Congress and the White House are assembling a spending package with billions in emergency spending and new...more

Capitol Hill Healthcare Update - February 2020 #3

AZAR TO TESTIFY THIS WEEK BEFORE HOUSE, SENATE COMMITTEES - Health and Human Services Secretary Alex Azar faces a marathon week of testimony, appearing before four congressional committees to discuss his department’s...more

Capitol Hill Healthcare Update - February 2020 #2

SURPRISE BILLING PROGRESS DRIVES THE WEEK - Legislation to address surprise medical bills is moving forward this week, as two House committees mark up their own plans to protect patients....more

Capitol Hill Healthcare Update

YEAR-END LEGISLATIVE OVERDRIVE - This week is crunch time on a host of legislative priorities, and various health-related provisions hang in the balance....more

Capitol Hill Healthcare Update

COMPREHENSIVE DRUG BILL STALLS WHILE HOUSE PUSHES SMALLER MEASURES - House Democrats are planning to take up more narrow bills addressing prescription drug costs while their broad legislation is delayed as the...more

Capitol Hill Healthcare Update

HOUSE DEMOCRATS PRESS FORWARD ON DRUG PRICING LEGISLATION - Returning from a two-week recess, House Democrats are entering a key phase in their drive to overhaul prescription drug costs, including requiring the government...more

Capitol Hill Healthcare Update

PELOSI DRUG PRICE PLAN EXPECTED THIS WEEK - House Speaker Nancy Pelosi, D-Calif., is expected to release her long-awaited plan this week to address prescription drug costs, according to congressional staff....more

Capitol Hill Healthcare Update

UPDATE ON DRUG PRICING LEGISLATION AS CONGRESS RECONVENES - Congress reconvenes this week after a monthlong summer recess and begins what likely will be a final push toward overhauling prescription drug prices, but lack of...more

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. MAJOR HEALTH POLICY UNLIKELY IN POTENTIAL DEBT-SPENDING DEAL - As House Speaker Nancy Pelosi, D-Calif., and...more

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session....more

The Weekly Hill Update

Below is the Federal Policy team’s weekly preview, published when Congress is in session. HEADLINES - • The House will take up a legislative package aiming to shore up the Affordable Care Act and address prescription...more

The Weekly Hill Update

Below is the Federal Policy team’s weekly preview, published when Congress is in session. HEADLINES - • Congress returns this week from a two-week recess, with the House continuing to showcase Democrats’ legislative...more

The Weekly Hill Update

Below is the Federal Policy team’s weekly preview, published when Congress is in session. HEADLINES - • Prescription drug costs will be back in the spotlight as the Senate Finance Committee holds a hearing focused on...more

The Weekly Hill Update

Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES - • The House will take up H.R. 1, a broad measure addressing voting rights, campaign finance and government...more

Finger-pointing But Few Fireworks at Senate Hearing on Drug Prices

Amid finger-pointing but few real fireworks, the seven pharmaceutical executives testifying before the Senate Finance Committee today offered lawmakers a spirited defense of the industry but also substantive policy...more

The Weekly Hill Update

Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES - • President Donald Trump will travel to Vietnam for his second meeting with North Korean leader Kim...more

The Weekly Hill Update

Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES - Negotiations over border security legislation have stalled, casting doubt on government funding beyond this...more

Capitol Hill Healthcare Update

Highlights this week: The Senate will give the final OK to opioids legislation, HHS gets full-year funding for the first time in forever, new bipartisan legislation would allow FDA to update labels on older generic drugs, and...more

The Weekly Hill Update

HEADLINES - Foreign policy is likely to lead headlines this week, as President Trump plans to decide whether the U.S. will remain in President Obama’s Iran nuclear deal, and he may also announce specifics on a plan to meet...more

Capitol Hill Healthcare Update

CONGRESS WORKS TO PASS BUDGET BEFORE FRIDAY’S SHUTDOWN DEADLINE - House leaders are pushing to schedule a vote this week on a $1.3 trillion budget agreement that would give the Senate enough time to pass it before a Friday...more

Capitol Hill Healthcare Update

HOUSE VOTE SET FOR UPDATED ‘RIGHT-TO-TRY’ LEGISLATION - The House will vote Tuesday on updated but still controversial legislation that would give terminally ill patients wider access to prescription drugs that haven’t won...more

Capitol Hill Healthcare Update

House Republicans will gather tonight for a GOP-only meeting to plot strategy on passing a stopgap budget bill, but a breakdown among key senators on separate immigration legislation has elevated the risk of a government...more

Capitol Hill Healthcare Update

Legislation reauthorizing FDA user fees for prescription and generic drugs, biosimilars, and medical devices won wide bipartisan approval last week in a Senate committee, teeing up approval by the full Senate, likely after...more

25 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide